15:21 ET -- Abbott Laboratories is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. It reported lower quarterly earnings but noted that full-year results "significantly exceeded the EPS guidance" provided at the beginning of 2022. For the fourth quarter, adjusted earnings per share declined to $1.03 from $1.32 and Covid-19 testing-related sales fell to $1.07 billion from $2.32 billion. Abbott said the shift of the pandemic to an endemic state has resulted in "significantly lower expected demand" for tests. Dow Jones & Co. owns Factiva. (josh.beckerman@wsj.com)

(END) Dow Jones Newswires

January 25, 2023 15:36 ET (20:36 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Abbott Laboratories
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Abbott Laboratories